Live Breaking News & Updates on Lecanemab Clarity|Page 5

Stay updated with breaking news from Lecanemab clarity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Controversial Alzheimer's drug Aduhelm is being discontinued, company says

Biogen will stop developing its Alzheimer's treatment Aduhelm, a drug once seen as a potential blockbuster before stumbling after its launch a couple years ago. ....

United Kingdom , Biogen Inc , Drug Administration , Massachusetts Based Biogen , United States , Biogen Inc , Health Medical Pharma , Eisai Co , Accelerated Approval , Spinal Muscular Atrophy , Alzheimer X27s Disease ,

Biogen Discontinues Aducanumab for Alzheimer Disease

Biogen has officially announced its decision to discontinue all development and sales of aducanumab (Aduhelm) for Alzheimer disease. ....

Zerbor Adobestock , George Vradenburg , Chris Viehbacher , Drug Administration , Eisai Partnered Leqembi ,

'It's a gamechanger & it's a reason for hope,' neurologist describes new Alzheimer's drug

On Dec. 1, 2023, UNC Health Pardee became the first hospital in WNC to administer a dose of a new Alzheimer’s drug that has shown promising benefits. ....

North Carolina , United States , Joel Callahan , Health Pardee , Western North Carolina , Health Medical Pharma , Wes Callahan , Groundbreaking Alzheimer , Alzheimer X27s Disease ,